← Leaderboards
Wenjun Guo
Whitehead Institute For Biomedical Res
$4,239,406
Attributed
$4,239,406
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $974.2K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,239,406 · 4
By mechanism
R01$2,429,182 · 2
P01$1,695,752 · 1
F32$114,472 · 1
Top collaborators
No co-investigators on record.
Most similar at Whitehead Institute For Biomedical Res
Same institution · by research overlap
- Ilaria Rebay$11,678,945
- Andrea L. Richardson$163,160
- Tong Ihn Lee$1,032,356
- Piyush Gupta$2,137,500
- Katherine Jean Wert$1,371,752
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmCancer CellCellsStem CellsPlayTumorBreast Cancer CellPropertyMolecularMalignant NeoplasmsCancer EtiologyGeneticStem-Like CellEnzymesNeoplasm MetastasisCancer TherapyTumor InitiationIn VivoStem Cell ExpansionBreastMediatingMesenchymalSignal PathwayMammary
Grant awards (12)
Targeting lineage plasticity to inhibit basal-like breast cancer progression$543,221
R01 · FY2025 · CA · contact PI
Role of SOX9 mammary stem cell factor in metastasis$430,947
P01 · FY2025 · CA · contact PI
Role of SOX9 mammary stem cell factor in metastasis$410,091
P01 · FY2024 · CA · contact PI
Role of the histone modifier MLL3 mutation in breast cancer cell plasticity$365,086
R01 · FY2024 · CA · contact PI
Role of SOX9 mammary stem cell factor in metastasis$423,041
P01 · FY2023 · CA · contact PI
Role of the histone modifier MLL3 mutation in breast cancer cell plasticity$376,614
R01 · FY2023 · CA · contact PI
Role of SOX9 mammary stem cell factor in metastasis$431,673
P01 · FY2022 · CA · contact PI
Role of the histone modifier MLL3 mutation in breast cancer cell plasticity$376,614
R01 · FY2022 · CA · contact PI
Role of the histone modifier MLL3 mutation in breast cancer cell plasticity$384,300
R01 · FY2021 · CA · contact PI
Role of the histone modifier MLL3 mutation in breast cancer cell plasticity$383,347
R01 · FY2020 · CA · contact PI
Epithelial-mesenchymal transition in stem cell induction and maintenance$58,682
F32 · FY2011 · CA · contact PI
Epithelial-mesenchymal transition in stem cell induction and maintenance$55,790
F32 · FY2010 · CA · contact PI